# The Effects of Nanomicelles Curcumin on Glycemic Control, Serum Lipid Profile ,Blood Pressure and Anthropometric Measurements in Patients With Metabolic Syndrome

> **NCT03534024** · NA · UNKNOWN · sponsor: **National Nutrition and Food Technology Institute** · enrollment: 50 (estimated)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** nanomicielle curcumin
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT03534024
- **Lead sponsor:** National Nutrition and Food Technology Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-30
- **Primary completion:** 2019-08-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03534024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03534024, "The Effects of Nanomicelles Curcumin on Glycemic Control, Serum Lipid Profile ,Blood Pressure and Anthropometric Measurements in Patients With Metabolic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03534024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*